104 related articles for article (PubMed ID: 19901837)
1. Bladder weight and detrusor thickness as parameters of progression of benign prostatic hyperplasia.
Tubaro A; Mariani S; De Nunzio C; Miano R
Curr Opin Urol; 2010 Jan; 20(1):37-42. PubMed ID: 19901837
[TBL] [Abstract][Full Text] [Related]
2. [Study on the change of bladder wall weight pre and after surgery in patients with benign prostatic hyperplasia].
Li HZ; Zhang XB; Li JC; Xiao H; Huang ZM
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):954-6. PubMed ID: 17961378
[TBL] [Abstract][Full Text] [Related]
3. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
[TBL] [Abstract][Full Text] [Related]
4. Modifications of the bladder wall (organ damage) in patients with bladder outlet obstruction: ultrasound parameters.
Galosi AB; Mazzaferro D; Lacetera V; Muzzonigro G; Martino P; Tucci G
Arch Ital Urol Androl; 2012 Dec; 84(4):263-7. PubMed ID: 23427760
[TBL] [Abstract][Full Text] [Related]
5. Comparative morphometric study of bladder detrusor between patients with benign prostatic hyperplasia and controls.
Inui E; Ochiai A; Naya Y; Ukimura O; Kojima M
J Urol; 1999 Mar; 161(3):827-30. PubMed ID: 10022694
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound estimated bladder weight and measurement of bladder wall thickness--useful noninvasive methods for assessing the lower urinary tract?
Bright E; Oelke M; Tubaro A; Abrams P
J Urol; 2010 Nov; 184(5):1847-54. PubMed ID: 20846683
[TBL] [Abstract][Full Text] [Related]
7. International Consultation on Incontinence-Research Society (ICI-RS) report on non-invasive urodynamics: the need of standardization of ultrasound bladder and detrusor wall thickness measurements to quantify bladder wall hypertrophy.
Oelke M
Neurourol Urodyn; 2010 Apr; 29(4):634-9. PubMed ID: 20432327
[TBL] [Abstract][Full Text] [Related]
8. The resolution of detrusor over activity after medical and surgical treatment in patients with bladder outlet obstruction.
Sriplakich S; Promwatcharanon K
J Med Assoc Thai; 2007 Nov; 90(11):2326-31. PubMed ID: 18181315
[TBL] [Abstract][Full Text] [Related]
9. Analysis of maximum detrusor contraction power in relation to bladder emptying in patients with lower urinary tract symptoms and benign prostatic enlargement.
Rosier PF; de Wildt MJ; de la Rosette JJ; Debruyne FM; Wijkstra H
J Urol; 1995 Dec; 154(6):2137-42. PubMed ID: 7500477
[TBL] [Abstract][Full Text] [Related]
10. Detrusor contraction duration as a urodynamic parameter of bladder outlet obstruction for evaluating men with lower urinary tract symptoms.
Ameda K; Steele GS; Sullivan MP; Stember D; Yalla SV
J Urol; 1998 Aug; 160(2):482-6. PubMed ID: 9679903
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology and differential diagnosis of benign prostatic hypertrophy.
Blaivas JG
Urology; 1988 Dec; 32(6 Suppl):5-11. PubMed ID: 2462303
[TBL] [Abstract][Full Text] [Related]
12. The effect of sildenafil citrate on bladder outlet obstruction: a mouse model.
Beamon CR; Mazar C; Salkini MW; Phull HS; Comiter CV
BJU Int; 2009 Jul; 104(2):252-6. PubMed ID: 19154466
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of isometric detrusor pressure in patients with benign prostatic hyperplasia].
Nishimoto K
Hinyokika Kiyo; 1990 Jan; 36(1):19-26. PubMed ID: 1689929
[TBL] [Abstract][Full Text] [Related]
14. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
[TBL] [Abstract][Full Text] [Related]
15. Imaging in benign prostatic hyperplasia: what is new?
Abdi H; Kazzazi A; Bazargani ST; Djavan B; Telegrafi S
Curr Opin Urol; 2013 Jan; 23(1):11-6. PubMed ID: 23138467
[TBL] [Abstract][Full Text] [Related]
16. The role of combination medical therapy in benign prostatic hyperplasia.
Greco KA; McVary KT
Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
van Venrooij GE; Eckhardt MD; Boon TA
Urology; 2004 Mar; 63(3):476-80. PubMed ID: 15028441
[TBL] [Abstract][Full Text] [Related]
18. Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it?
da Silva CM; Cruz F
Curr Opin Urol; 2009 Jul; 19(4):347-52. PubMed ID: 19444121
[TBL] [Abstract][Full Text] [Related]
19. The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction.
de Nunzio C; Franco G; Rocchegiani A; Iori F; Leonardo C; Laurenti C
J Urol; 2003 Feb; 169(2):535-9. PubMed ID: 12544303
[TBL] [Abstract][Full Text] [Related]
20. Reversible change of bladder hypertrophy due to benign prostatic hyperplasia after surgical relief of obstruction.
Kojima M; Inui E; Ochiai A; Naya Y; Kamoi K; Ukimura O; Watanabe H
J Urol; 1997 Jul; 158(1):89-93. PubMed ID: 9186330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
